Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSavills Regulatory News (SVS)

Share Price Information for Savills (SVS)

Share Price is delayed by 15 minutes
Get Live Data
822.00    14.00 (1.73%)
Bid:
816.00
Ask:
819.00
Spread: 3.00 (0.368%)
Market Cap: £1.14b
SVS Live PriceLast checked at - London Stock Exchange

Intraday Savills Share Chart

AGM Statement

8 May 2019 10:04

RNS Number : 3697Y
Savills PLC
08 May 2019
 

 

8 May 2019

SAVILLS PLC

("Savills" or "the Company")

AGM Statement

 

Savills plc, the international real estate advisor, is today holding its Annual General Meeting (AGM) at 12 noon, 33 Margaret Street, London, W1G 0JD, and provides the following AGM statement.

 

During the year to date the Group has traded in line with our expectations. Globally, our transaction businesses have continued to maintain strong market shares although, as anticipated, volumes in certain markets have been subdued as a result of political and economic uncertainty. Our Consultancy, Property Management and Investment Management businesses have continued to perform well.

 

In the UK, trading has been resilient despite increased political uncertainty. In our Residential Transaction business there has been a healthy increase in indicators which are normally a precursor to increased market activity. Of particular note is strong double digit increases in new buyers registered and a year-on-year increase in revenue in the prime Central London market. The Commercial Transaction business is also proving resilient, particularly in Central London, however, volumes across the UK have declined and development activity is relatively subdued.

 

In Asia Pacific, Savills has had a good start to the year, with Hong Kong, Mainland China, Singapore and Vietnam showing year-on-year revenue growth.

 

In North America, the business has successfully rebranded to Savills and continued its strong revenue performance from Q4 2018 through the period, with corporates generally active in relatively benign market conditions. The New York, Washington and Californian markets have proved particularly active to date.

 

In Continental Europe and the Middle East, we have traded in line with our expectations, with good year-on-year revenue growth in Ireland, France, the Netherlands and the Czech Republic. In Sweden, the new Capital markets and leadership team have started well accumulating a strong pipeline of potential transaction activity for the second half of the year.

 

Savills Investment Management has performed as expected. As previously announced, we successfully concluded the search for a new CEO for Savills Investment Management , with Alex Jeffrey due to join the firm later in the year.

 

Whilst the year has started as expected, the first few months typically represent a relatively modest proportion of the expected outturn for the full year. In the UK market, there remains significant investor demand but commercial transaction activity in the next few months may continue to be overshadowed by the prolonged uncertainty over Brexit, the exact impact of which is difficult to determine at present. We do, however, expect some strengthening of activity in certain overseas markets and, despite a greater weighting towards H2 than last year, we continue to anticipate overall performance for 2019 to be in line with our expectations.

 

For further information, contact:

 

Savills 020 7409 8934

Mark Ridley, Group Chief Executive

Simon Shaw, Group Chief Financial Officer

 

Tulchan Communications 020 7353 4200

David Allchurch

Elizabeth Snow

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGMLIFIAELITIIA
Date   Source Headline
2nd Dec 202410:00 amRNSTotal Voting Rights
26th Nov 20243:34 pmRNSHolding(s) in Company
22nd Nov 20242:00 pmRNSAdditional Listing
15th Nov 20242:58 pmRNSHolding(s) in Company
14th Nov 20241:53 pmRNSHolding(s) in Company
13th Nov 20241:47 pmRNSHolding(s) in Company
12th Nov 20242:51 pmRNSDirector/PDMR Shareholding
12th Nov 20242:48 pmRNSHolding(s) in Company
11th Nov 20242:25 pmRNSHolding(s) in Company
1st Nov 202411:00 amRNSTotal Voting Rights
14th Oct 20249:52 amRNSDirector/PDMR Shareholding
4th Oct 20242:00 pmRNSAdditional Listing
1st Oct 202411:00 amRNSTotal Voting Rights
18th Sep 20242:43 pmRNSDirector Declaration
16th Sep 20243:50 pmRNSDirector Declaration
12th Sep 20241:47 pmRNSDirector/PDMR Shareholding
2nd Sep 202411:00 amRNSTotal Voting Rights
29th Aug 20242:24 pmRNSDirector/PDMR Shareholding
15th Aug 202411:00 amRNSBlock listing Interim Review
13th Aug 20243:17 pmRNSDirector/PDMR Shareholding
8th Aug 20247:00 amRNSHalf-year Report
1st Aug 202411:00 amRNSTotal Voting Rights
30th Jul 20242:11 pmRNSHolding(s) in Company
22nd Jul 20242:36 pmRNSBlock listing Interim Review
11th Jul 20244:26 pmRNSDirector/PDMR Shareholding
1st Jul 20249:27 amRNSTotal Voting Rights
20th Jun 202410:36 amRNSDirector/PDMR Shareholding
13th Jun 20241:37 pmRNSDirector/PDMR Shareholding
11th Jun 20244:42 pmRNSDirector/PDMR Shareholding
7th Jun 20244:01 pmRNSDirector/PDMR Shareholding
4th Jun 20242:43 pmRNSDirector/PDMR Shareholding
3rd Jun 202411:00 amRNSTotal Voting Rights
23rd May 20242:21 pmRNSDirector/PDMR Shareholding
17th May 20243:44 pmRNSDirector/PDMR Shareholding
15th May 20243:06 pmRNSResult of AGM
15th May 202410:02 amRNSAGM Statement
14th May 20248:00 amRNSDirector/PDMR Shareholding
2nd May 20248:28 amRNSTotal Voting Rights
26th Apr 20242:13 pmRNSDirector/PDMR Shareholding
26th Apr 202411:21 amRNSDirector Declaration
15th Apr 20243:42 pmRNSDirector/PDMR Shareholding
12th Apr 20245:12 pmRNSDirector/PDMR Shareholding
8th Apr 20243:47 pmRNSAnnual Report and AGM Notice
21st Mar 20248:17 amRNSDirector/PDMR Shareholding
19th Mar 20245:11 pmRNSHolding(s) in Company
14th Mar 20247:00 amRNSNon-Executive Director Appointment
14th Mar 20247:00 amRNSFinal Results
13th Mar 20241:37 pmRNSDirector/PDMR Shareholding
15th Feb 202410:00 amRNSBlock listing Interim Review
13th Feb 20246:07 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.